FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028283753> ?p ?o ?g. }

• W2028283753 endingPage "451" @default.
• W2028283753 startingPage "441" @default.
• W2028283753 abstract "Topical application of imiquimod (IMQ) on the skin of mice induces inflammation with common features found in psoriatic skin. Recently, it was postulated that IL-17 has an important role both in psoriasis and in the IMQ model. To further investigate the impact of IL-17RA signaling in psoriasis, we generated IL-17 receptor A (IL-17RA)–deficient mice (IL-17RAdel) and challenged these mice with IMQ. Interestingly, the disease was only partially reduced and delayed but not abolished when compared with controls. In the absence of IL-17RA, we found persisting signs of inflammation such as neutrophil and macrophage infiltration within the skin. Surprisingly, already in the naive state, the skin of IL-17RAdel mice contained significantly elevated numbers of Th17- and IL-17-producing γδ T cells, assuming that IL-17RA signaling regulates the population size of Th17 and γδ T cells. Upon IMQ treatment of IL-17RAdel mice, these cells secreted elevated amounts of tumor necrosis factor-α, IL-6, and IL-22, accompanied by increased levels of the chemokine CXCL2, suggesting an alternative pathway of neutrophil and macrophage skin infiltration. Hence, our findings have major implications in the potential long-term treatment of psoriasis by IL-17-targeting drugs. Topical application of imiquimod (IMQ) on the skin of mice induces inflammation with common features found in psoriatic skin. Recently, it was postulated that IL-17 has an important role both in psoriasis and in the IMQ model. To further investigate the impact of IL-17RA signaling in psoriasis, we generated IL-17 receptor A (IL-17RA)–deficient mice (IL-17RAdel) and challenged these mice with IMQ. Interestingly, the disease was only partially reduced and delayed but not abolished when compared with controls. In the absence of IL-17RA, we found persisting signs of inflammation such as neutrophil and macrophage infiltration within the skin. Surprisingly, already in the naive state, the skin of IL-17RAdel mice contained significantly elevated numbers of Th17- and IL-17-producing γδ T cells, assuming that IL-17RA signaling regulates the population size of Th17 and γδ T cells. Upon IMQ treatment of IL-17RAdel mice, these cells secreted elevated amounts of tumor necrosis factor-α, IL-6, and IL-22, accompanied by increased levels of the chemokine CXCL2, suggesting an alternative pathway of neutrophil and macrophage skin infiltration. Hence, our findings have major implications in the potential long-term treatment of psoriasis by IL-17-targeting drugs. imiquimod psoriasis area and severity index wild-type" @default.
• W2028283753 created "2016-06-24" @default.
• W2028283753 creator A5000821688 @default.
• W2028283753 creator A5006091584 @default.
• W2028283753 creator A5009280452 @default.
• W2028283753 creator A5009674729 @default.
• W2028283753 creator A5025746046 @default.
• W2028283753 creator A5032894837 @default.
• W2028283753 creator A5035254382 @default.
• W2028283753 creator A5050244939 @default.
• W2028283753 creator A5062206937 @default.
• W2028283753 creator A5063165810 @default.
• W2028283753 creator A5065994712 @default.
• W2028283753 creator A5075827987 @default.
• W2028283753 creator A5080496100 @default.
• W2028283753 creator A5089332488 @default.
• W2028283753 creator A5089394271 @default.
• W2028283753 date "2013-02-01" @default.
• W2028283753 modified "2023-10-12" @default.
• W2028283753 title "An Alternative Pathway of Imiquimod-Induced Psoriasis-Like Skin Inflammation in the Absence of Interleukin-17 Receptor A Signaling" @default.
• W2028283753 cites W1493159751 @default.
• W2028283753 cites W1508320954 @default.
• W2028283753 cites W1515725948 @default.
• W2028283753 cites W1571249274 @default.
• W2028283753 cites W1939997832 @default.
• W2028283753 cites W1968963646 @default.
• W2028283753 cites W1969629598 @default.
• W2028283753 cites W1971708477 @default.
• W2028283753 cites W1973131450 @default.
• W2028283753 cites W1975162362 @default.
• W2028283753 cites W1978172024 @default.
• W2028283753 cites W1979530431 @default.
• W2028283753 cites W1986175684 @default.
• W2028283753 cites W1989001888 @default.
• W2028283753 cites W1994576750 @default.
• W2028283753 cites W1995901066 @default.
• W2028283753 cites W2002258757 @default.
• W2028283753 cites W2012077729 @default.
• W2028283753 cites W2012097026 @default.
• W2028283753 cites W2016564842 @default.
• W2028283753 cites W2019678439 @default.
• W2028283753 cites W2022022413 @default.
• W2028283753 cites W2042139075 @default.
• W2028283753 cites W2045940178 @default.
• W2028283753 cites W2047344004 @default.
• W2028283753 cites W2054230488 @default.
• W2028283753 cites W2058863496 @default.
• W2028283753 cites W2064201575 @default.
• W2028283753 cites W2064464816 @default.
• W2028283753 cites W2065136791 @default.
• W2028283753 cites W2070840302 @default.
• W2028283753 cites W2078827499 @default.
• W2028283753 cites W2082622860 @default.
• W2028283753 cites W2083524155 @default.
• W2028283753 cites W2094036101 @default.
• W2028283753 cites W2105410310 @default.
• W2028283753 cites W2107277218 @default.
• W2028283753 cites W2112133235 @default.
• W2028283753 cites W2118140057 @default.
• W2028283753 cites W2121126920 @default.
• W2028283753 cites W2125941916 @default.
• W2028283753 cites W2126162679 @default.
• W2028283753 cites W2127997822 @default.
• W2028283753 cites W2135402306 @default.
• W2028283753 cites W2145634436 @default.
• W2028283753 cites W2153509968 @default.
• W2028283753 cites W2155974661 @default.
• W2028283753 cites W2156762273 @default.
• W2028283753 cites W2159513688 @default.
• W2028283753 cites W2160883911 @default.
• W2028283753 cites W2166518409 @default.
• W2028283753 cites W4361866506 @default.
• W2028283753 cites W92886133 @default.
• W2028283753 cites W2098751820 @default.
• W2028283753 doi "https://doi.org/10.1038/jid.2012.318" @default.
• W2028283753 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22951726" @default.
• W2028283753 hasPublicationYear "2013" @default.
• W2028283753 type Work @default.
• W2028283753 sameAs 2028283753 @default.
• W2028283753 citedByCount "135" @default.
• W2028283753 countsByYear W20282837532013 @default.
• W2028283753 countsByYear W20282837532014 @default.
• W2028283753 countsByYear W20282837532015 @default.
• W2028283753 countsByYear W20282837532016 @default.
• W2028283753 countsByYear W20282837532017 @default.
• W2028283753 countsByYear W20282837532018 @default.
• W2028283753 countsByYear W20282837532019 @default.
• W2028283753 countsByYear W20282837532020 @default.
• W2028283753 countsByYear W20282837532021 @default.
• W2028283753 countsByYear W20282837532022 @default.
• W2028283753 countsByYear W20282837532023 @default.
• W2028283753 crossrefType "journal-article" @default.
• W2028283753 hasAuthorship W2028283753A5000821688 @default.
• W2028283753 hasAuthorship W2028283753A5006091584 @default.
• W2028283753 hasAuthorship W2028283753A5009280452 @default.
• W2028283753 hasAuthorship W2028283753A5009674729 @default.
• W2028283753 hasAuthorship W2028283753A5025746046 @default.
• W2028283753 hasAuthorship W2028283753A5032894837 @default.

• next